Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Hadad

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Clinical Nephrology. Case Studies|January 14, 2022
The "new normal" osmotic threshold: Osmostat resetLarissa G Rigueto, Henrique M Santiago, David J Hadad, et al.
Biomed Research International|February 23, 2019
Daily 800 mg versus 600 mg Efavirenz for HIV Patients Treating Tuberculosis with a Rifampicin-Based Regimen: An Open Label Randomized Controlled TrialMariana S Xavier, Anete Trajman, Carolina A S Schmaltz, et al.
The Lancet. Infectious Diseases|March 18, 2020
Mycobacterium tuberculosis bloodstream infection prevalence, diagnosis, and mortality risk in seriously ill adults with HIV: a systematic review and meta-analysis of individual patient dataDavid A Barr, Joseph M Lewis, Nicholas Feasey, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Clinical Nephrology. Case Studies|January 14, 2022
The "new normal" osmotic threshold: Osmostat resetLarissa G Rigueto, Henrique M Santiago, David J Hadad, et al.
Biomed Research International|February 23, 2019
Daily 800 mg versus 600 mg Efavirenz for HIV Patients Treating Tuberculosis with a Rifampicin-Based Regimen: An Open Label Randomized Controlled TrialMariana S Xavier, Anete Trajman, Carolina A S Schmaltz, et al.
The Lancet. Infectious Diseases|March 18, 2020
Mycobacterium tuberculosis bloodstream infection prevalence, diagnosis, and mortality risk in seriously ill adults with HIV: a systematic review and meta-analysis of individual patient dataDavid A Barr, Joseph M Lewis, Nicholas Feasey, et al.
Pageof 1